Cell Impact AB

Stockholm, February 20, 2013

NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Cell Impact AB (short name: CI B) shares will commence today on First North at NASDAQ OMX Stockholm. Cell Impact, a spin-off company from Amasten (previously Morphic Technologies), belongs to the Industrial sector and is the fourth new company to be admitted to trading on First North in 2013.

Cell Impact develops and markets high velocity impact units – a patented and innovative technology that acts to create a more sustainable society. The technology can be used to shape and shear material by using high kinetic energy, thus providing new opportunities in terms of improved quality for a wide area of applications. For more information, visit www.cellimpact.se

Follow the Cell Impact share here


Click for full size image CEO Mats Wallin tolls the bell to open the market. 

Click for full size image  Kjell Östergren,Board member, Jan Rynning, Chairman & Mats Walin, CEO

Click for full size image  CEO Mats Wallin

Click for full size image  The Cell Impact team together with their certified adviser, Mangold Fondkommission and the NASDAQ OMX team.

Click for full size image  Mats Wallin, CEO of Cell Impact is welcomed by Marie Parck, NASDAQ OMX